Join the Schizophrenia group to help and get support from people like you.
Schizophrenia News (Page 4)
Related terms: Catatonic Schizophrenia, Disorganized Schizophrenia, Paranoid Schizophrenia, Residual Schizophrenia, Schizophrenia, catatonic, Schizophrenia, disorganized, Schizophrenia, paranoid, Schizophrenia, residual, Schizophrenia, undifferentiated, Undifferentiated Schizophrenia
Rates of Sexual Dysfunction High in Patients With Schizophrenia
FRIDAY, Sept. 15, 2023 – There is a high prevalence of sexual dysfunction among individuals with schizophrenia, according to a review published online Sept. 13 in JAMA Psychiatry. Théo Korchia, ...
Tobacco, Cannabis Use Tied to High Rates of Self-Reported Mental Health Issues
FRIDAY, Sept. 15, 2023 – Use of tobacco and/or cannabis, particularly co-use of both substances, is associated with poor mental health, according to a study published online Sept. 13 in PLOS ONE....
ADHD Is Independent Risk Factor for Psychiatric Disorders
THURSDAY, Sept. 7, 2023 – Attention-deficit hyperactivity disorder (ADHD) is an independent risk factor for certain psychiatric disorders, including anorexia nervosa and major depressive disorder,...
Smoking Increases Risk for Mental Illness
TUESDAY, Sept. 5, 2023 – Smoking increases the risk for developing mental disorders, according to a study published online Aug. 21 in Acta Psychiatrica Scandinavica. Lloyd Balbuena, from University...
Higher Risk for Schizophrenia Seen Among Patients With Eczema
TUESDAY, Aug. 8, 2023 – Having atopic dermatitis is associated with a higher risk for schizophrenia and schizoaffective disorder, according to a study published online July 26 in the Archives of...
Bipolar Disorder Ups Early Death Risk by Sixfold
WEDNESDAY, July 19, 2023 – People who have bipolar disorder may have a higher risk of dying early, according to new research. Finnish investigators say this is due to a combination of external...
Pets Don't Help Those With Severe Mental Illness Fare Better
MONDAY, July 17, 2023 – It’s commonly thought that having a companion animal — be it a dog, cat or bird — is good for the owner’s mental health. A new study suggests that’s not so, at least for peopl...
Expressing Yourself Creatively Gives Mental Health Boost, Poll Finds
FRIDAY, July 7, 2023 – One way to get real peace of mind: Start doing something creative. Americans who engage in creative activities – from crafting to playing the piano to painting --- report...
Fewer Kids Are Being Prescribed Antipsychotic Meds
FRIDAY, July 7, 2023 – The use of antipsychotic medication in children is continuing to plummet, likely because of better policies and education, new research shows. The study found a 43% drop in...
Program Helps Folks Battling Mental Illness Beat Another Foe: Smoking
WEDNESDAY, July 5, 2023 – Dr. Richard Stumacher’s coworker at Northwell Health in New York City used to smoke to curb her severe anxiety, and tried multiple times to stop. “She went through the pro...
FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
PARSIPPANY, N.J., TEL AVIV & PARIS, April 28, 2023 – Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced t...
FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
April 28, 2023 – Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA)...
FDA Approves Rykindo (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Bipolar 1 Disorder
PRINCETON, N.J., Jan. 15, 2023 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today ...
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for Caplyta (lumateperone) for Specific Patient Populations
Caplyta label now includes dosage recommendations for specific patient populations; those with moderate or severe hepatic impairment and patients who are concomitantly taking moderate or strong...
FDA Approves Igalmi (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults
NEW HAVEN, Conn., April 06, 2022 (GLOBE NEWSWIRE) – BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence (AI) approaches to identify and develop...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
Seroquel, Abilify, Latuda, quetiapine, Vraylar, olanzapine, risperidone, Zyprexa, aripiprazole, view more... Risperdal, Rexulti, Seroquel XR, Geodon, Invega, Invega Sustenna